Pediatricians’ COVID-19 experiences and views on the willingness to receive COVID-19 vaccines: a cross-sectional survey in Turkey

Figures & data

Table 1. Demographic characteristics of pediatricians

Characteristics	Data n (%)
Survey response rate	506/2251 (22%)
Gender
Male	209 (42%)
Female	297 (58%)
Age (years)
26–35	169 (33%)
36–44	168 (33)
45–60	153 (30%)
>60	16 (4%)
Presence of chronic diseases	89 (18%)
Having a child	379 (75%)
Tobacco use	70 (14%)
Specialty area
Pediatrician	190 (49%)
Pediatric subspecialist	82 (21)
Instutition
Private hospitals	225 (44%)
University and teaching hospitals	110 (22%)
State hospitals	136 (27%)
Doctor office	32 (6%)
City
Istanbul	224
Ankara	27
Bursa	17
Kocaeli	16
Tekirdağ	15
İzmir	14
Sakarya	11
Diyarbakır	11
Tokat	11
Konya	10
Antalya	10
Gaziantep	9
Batman	9
Others	122

Table 2. Responses of pediatricians to COVID-19-related questions

Quotes	Total (n)	Yes n,%	No n,%
Serve for COVID-19 suspected or infected children	506	424 (84%)	82 (16%)
History of a having a COVID-19 test (either PCR or antibody assay)	506	362 (72%)	144 (28%)
History of infection with SARS-CoV2 during the pandemic	506	71 (14%)	435 (86%)
Any of family members infected with SARS-CoV-2	506	105 (20%)	401 (80%)
Any of close circle friends infected with SARS-CoV-2	506	395 (78%)	111 (22%)
Any of your close friends or family member death due to COVID-19	506	115 (23%)	391 (77%)
Source of COVID-19 related information
(a) Regularly following literature	506	373 (73%)	-
(b) Ministry of Health announces	506	39 (8%)	-
(c) Social media and newspapers	506	94 (19%)	-
Believe that effective COVID-19 vaccine will be developed	506	340 (67%)	166 (33%)
Most important factor for COVID-19 vaccine acceptance
(a) Safety of vaccine	506	293 (57%)	-
(b) Protectivity of vaccine	506	206 (41%)
(c) Country of vaccine manufacturer	506	6 (1%)
(d) Price of vaccine	506	1 (1%)
Willing to participate as a subject in phase 2 COVID-19 vaccine research	506	79 (16%)	427 (84%)
Willing to get vaccinated if effective COVID-19 vaccine available	506	420 (83%)	86 (17%)
Willing to vaccinate their family member if effective COVID-19 vaccine available	506	422 (83%)	84 (17%)
Willing to vaccinate their children member if effective COVID-19 vaccine available	506	380 (75)	126 (25%)
Willing to vaccinate their children member if effective COVID-19 vaccine available	506	445 (86%)	61 (14%)
COVID-19 vaccine knowledge level	506
(a) No idea	25 (4%)		-
(b) Got information from social media and newspaper	91 (17%)
(c) Reading regularly scientific articles	40 (7%)
(d) Just know phase 2 and 3 studies continued	350 (72%)
COVID-19 vaccine should be mandatory	506	303 (59%)	203 (41%)
COVID-19 vaccine passport should be mandatory for school entrance or travel	506	303 (59%)	203 (41%)
Which of the people should receive firstly COVID-19 vaccine in population if doses is limited	506
Healthcare workers	232(46%)
People with chronic diseases	173(34%)
People age over 65 years	76 (15%)
Children	8^2
Health adult	17^3
Which of the COVID-19 vaccine will be effective?	506
No idea	214(42%)
mRNA-based vaccines	113(22%)
Inactive whole viral vaccines	65(12%)
Attenuated live viral vaccines	72(14%)
Adenoviral vector-based vaccines	28(6%)
DNA vaccines	14(45)
What do you think about vaccination schedule of probable covid19 vaccine
Annual vaccination	285(57%)
Biannual period vaccination	7 (1%)
6 months interval vaccination	152(28%)
No idea	38 (9%)
Single dose for lifelong	24 (5%)
Which is the most effective strategy for stopping covid19 pandemic
Vaccination	342(68%)
Herd immunity	102(20%)
Total closure for 14 days	37 (7%)
Social distance	20 (5%)

Figure 1. Pediatricians’ willingness for influenza and COVID-19 vaccines upon themselves, family members, their child/children and their pediatric patients

Table 3. Factors associated with acceptance of COVID-19 vaccination in pediatricians

Features of pediatricians	Total number (n=)	COVID-19 vaccine acceptant n = (%)	COVID-19 vaccine non-acceptant n = (%)	P value
Age
< 45 years	337	282 (83%)	55 (17%)	0.32
≥ 45 years	169	138 (81%)	31 (19%)
Gender
Female	297	236 (79%)	61 (21%)	0.01
Male	209	184 (88%)	25 (12%)
Specialty
Pediatrician	458	374 (82%)	84 (18%)
Pediatric subspecialist	48	46 (96%)	2(4)
Chronic Diseases				<0.01
Not present	417	345 (83%)	72 (17%)	0.12
Present	89	75 (84%)	14 (16%)
Tobacco Usage
No	436	362 (83%)	74 (17%)	0.79
Yes	70	59 (84%)	11 (16%)
Having a child
No	127	107 (84%)	20 (16%)	0.7
Yes	379	314 (82%)	65 (18%)
Covid-19 test (PCR or Ab)
Not done	144	121 (84%)	23 (16%)	0.69
Done	362	299 (83%)	63 (17%)
History of SARS-CoV2 infection
Not-infected	435	363 (83%)	72 (17%)	0.51
Infected	71	57 (80%)	14 (20%)
History of SARS-CoV2 infection in family
Not-infected	401	337 (84%)	64 (16%)	0.22
Infected	105	83 (79%)	22 (21%)
History of SARS-CoV2 infection in close friends
Not-infected	111	90 (81%)	21 (19%)	0.54
Infected	395	330 (83%)	65 (17%)
Dead due to COVID-19 in close friends/family
No	391	324 (82%)	67 (18%)	0.87
Yes	115	96 (83%)	19 (17%)
Serve for COVID-19 patients
No	82	68 (82%)	14 (18%)	0.98
Yes	424	352 (83%)	72 (17%)
Effective vaccine will be developed
No	166	110 (65%)	56 (35%)	<0.0001
Yes	340	310 (91%)	110 (9%)
Intent to be enrolled in phase 2 vaccine study
No	427	340 (73%)	85 (27%)	0.00004
Yes	79	78 (99%)	1 (1%)
COVID-19 vaccine should be mandatory
No	203	133	70	<0.00001
Yes	303	287	16
COVID-19 vaccine passport should be mandatory
No	203	135	68	<0.0001
Yes	303	285	18
Influenza vaccination in 2019 season				<0.0001
No	308	240 (77%)	68 (23%)
Yes	198	180 (90%)	18 (10%)
Willing to influenza vaccination in 2020
No	152	104 (68%)	48 (32%)	<0.0001
Yes	354	316 (89%)	38 (11%)

Lafaie L, Célarier T, Goethals L, Pozzetto B, Grange S, Ojardias E, Annweiler C, Botelho‐Nevers E. Recurrence or relapse of COVID-19 in older patients: a description of three cases. J Am Geriatr Soc. 2020;7. Online ahead of print. doi:10.1111/jgs.16728.

 Google Scholar